Skip to main content
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Stuart J. Connolly
Sign up to set email alerts
139
Publications
9,627
Citation Statements Received
2,569
Citation Statements Given
How they've been cited
15,163
234
9,360
33
How they cite others
3,863
53
2,502
14
Affiliations
Population Health Research Institute
,
McMaster University
Publications
Order By: Most citations
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
Eikelboom
1
,
Connolly
2
,
Bosch
3
et al.
2017
N Engl J Med
Abstract
Show
2,478
27
1,686
5
Get access via publisher
Add to collection
Cite
Apixaban in Patients with Atrial Fibrillation
Connolly
1
,
Eikelboom
2
,
Joyner
3
et al.
2011
N Engl J Med
2,358
22
1,427
1
Get access via publisher
Add to collection
Cite
Embolic strokes of undetermined source: the case for a new clinical construct
Hart
1
,
Diener
2
,
Coutts
3
et al.
2014
The Lancet Neurology
1,710
18
1,433
1
Get access via publisher
Add to collection
Cite
Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
Morillo
1
,
Marin‐Neto
2
,
Avezum
3
et al.
2015
N Engl J Med
Abstract
Show
1,062
19
894
2
Get access via publisher
Add to collection
Cite
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Anand
1
,
Bosch
2
,
Eikelboom
3
et al.
2018
The Lancet
Abstract
Show
902
16
550
1
Get access via publisher
Add to collection
Cite
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Moayyedi
1
,
Eikelboom
2
,
Bosch
3
et al.
2019
Gastroenterology
Abstract
Show
483
13
425
0
Get access via publisher
Add to collection
Cite
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
Connolly
1
2000
European Heart Journal
Abstract
Show
1,089
6
330
1
Get access via publisher
Add to collection
Cite
Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Healey
1
,
Baranchuk
2
,
Crystal
3
et al.
2005
Journal of the American College of Cardiology
Abstract
Show
774
10
282
3
Get access via publisher
Add to collection
Cite
1
2
3
